IL134289A0 - Methods for treating neurological deficits - Google Patents
Methods for treating neurological deficitsInfo
- Publication number
- IL134289A0 IL134289A0 IL13428998A IL13428998A IL134289A0 IL 134289 A0 IL134289 A0 IL 134289A0 IL 13428998 A IL13428998 A IL 13428998A IL 13428998 A IL13428998 A IL 13428998A IL 134289 A0 IL134289 A0 IL 134289A0
- Authority
- IL
- Israel
- Prior art keywords
- methods
- treating neurological
- neurological deficits
- deficits
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5538397P | 1997-08-04 | 1997-08-04 | |
PCT/US1998/016281 WO1999006060A1 (en) | 1997-08-04 | 1998-08-04 | Methods for treating neurological deficits |
Publications (1)
Publication Number | Publication Date |
---|---|
IL134289A0 true IL134289A0 (en) | 2001-04-30 |
Family
ID=21997438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13428998A IL134289A0 (en) | 1997-08-04 | 1998-08-04 | Methods for treating neurological deficits |
Country Status (9)
Country | Link |
---|---|
US (3) | US7790669B1 (xx) |
EP (1) | EP0996456A4 (xx) |
JP (1) | JP2001511456A (xx) |
KR (1) | KR20010022641A (xx) |
CN (1) | CN1273534A (xx) |
AU (1) | AU743251B2 (xx) |
CA (1) | CA2298506A1 (xx) |
IL (1) | IL134289A0 (xx) |
WO (1) | WO1999006060A1 (xx) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7795202B2 (en) | 1997-08-04 | 2010-09-14 | Neurorepair, Inc. | Methods for treating a neurological disorder by peripheral administration of a transforming growth factor alpha (TGF-a) |
US20010007657A1 (en) * | 1997-08-04 | 2001-07-12 | Reid James Steven | Compositions and methods for manipulating glial progenitor cells and treating neurological deficits |
AU743251B2 (en) | 1997-08-04 | 2002-01-24 | Regents Of The University Of California, The | Methods for treating neurological deficits |
CA2348292A1 (en) * | 1998-10-30 | 2000-05-11 | Takeda Chemical Industries, Ltd. | Betacellulin protein-containing preparation |
US20020099008A1 (en) | 1999-04-26 | 2002-07-25 | Daniel R. Twardzik | Method for stimulating hematopoiesis using tgf-alpha |
JP2002543096A (ja) | 1999-04-26 | 2002-12-17 | ステム セル ファーマシューティカルズ,インコーポレーテッド | TGF−αポリペプチド、機能性断片およびそれらの利用法 |
US6815418B2 (en) | 1999-08-19 | 2004-11-09 | Kaleidos Pharma, Inc. | TGF-α polypeptides, functional fragments and methods of use therefor |
US6677307B2 (en) | 1999-08-19 | 2004-01-13 | Kaleidos Pharma, Inc. | TGF-α polypeptides, functional fragments and methods of use therefor |
US20020193301A1 (en) | 1999-08-19 | 2002-12-19 | Stem Cell Pharmaceuticals, Inc. | TGF-alpha polypeptides, functional fragments and methods of use therefor |
CA2387748A1 (en) * | 1999-10-20 | 2001-04-26 | Stem Cells,Inc. | Methods for inducing in vivo proliferation and migration of transplanted progenitor cells in the brain |
AU1760201A (en) * | 1999-11-12 | 2001-06-06 | Fred Hutchinson Cancer Research Center | Methods for treatment of human huntington's disease and methods of screening foractive agents |
JP2002348239A (ja) * | 2000-10-05 | 2002-12-04 | Takeda Chem Ind Ltd | 幹細胞・神経前駆細胞の増殖・分化促進剤 |
WO2003028651A2 (en) * | 2001-10-02 | 2003-04-10 | Medical College Of Georgia Research Institute, Inc. | Antipsychotic agents stimulate neurogenesis in brain |
AU2002355033A1 (en) | 2001-11-29 | 2003-06-10 | Japan Science And Technology Agency | Method of constructing spinal injury model monkey and utilization thereof |
GB2421029B (en) * | 2003-08-29 | 2008-04-09 | Wisconsin Alumni Res Found | Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells |
CA2539947A1 (en) * | 2003-09-24 | 2005-04-07 | The Board Of Trustees Of The Leland Stanford Junior University | Igf-1 instructs multipotent adult cns neural stem cells to an oligodendroglial lineage |
US20050123526A1 (en) * | 2003-12-01 | 2005-06-09 | Medtronic Inc. | Administration of growth factors for neurogenesis and gliagenesis |
US20090028921A1 (en) | 2007-06-18 | 2009-01-29 | New Jersey Institute Of Technology | Electrospun Ceramic-Polymer Composite As A Scaffold For Tissue Repair |
US20090325296A1 (en) | 2008-03-25 | 2009-12-31 | New Jersey Institute Of Technology | Electrospun electroactive polymers for regenerative medicine applications |
US9192655B2 (en) | 2009-03-12 | 2015-11-24 | New Jersey Institute Of Technology | System and method for a hydrogel and hydrogel composite for cartilage repair applications |
US9476026B2 (en) | 2009-03-12 | 2016-10-25 | New Jersey Institute Of Technology | Method of tissue repair using a piezoelectric scaffold |
US9334476B2 (en) * | 2009-03-12 | 2016-05-10 | New Jersey Institute Of Technology | Method for nerve growth and repair using a piezoelectric scaffold |
US9771557B2 (en) | 2009-03-12 | 2017-09-26 | New Jersey Institute Of Technology | Piezoelectric scaffold for nerve growth and repair |
US9180166B2 (en) | 2010-03-12 | 2015-11-10 | New Jersey Institute Of Technology | Cartilage repair systems and applications utilizing a glycosaminoglycan mimic |
WO2012142533A1 (en) | 2011-04-13 | 2012-10-18 | New Jersey Institute Of Technology | System and method for electrospun biodegradable scaffold for bone repair |
WO2012171007A2 (en) * | 2011-06-09 | 2012-12-13 | University Of Florida Research Foundation, Inc. | Methods for treating or preventing graft versus host disease |
EP3541279B1 (en) * | 2016-11-15 | 2023-09-06 | The Regents of the University of California | Apparatuses for improving peripheral nerve function |
US10778561B2 (en) | 2017-09-08 | 2020-09-15 | Avago Technologies International Sales Pte. Limited | Diagnostic port for inter-switch and node link testing in electrical, optical and remote loopback modes |
EP3721896B1 (en) * | 2019-04-08 | 2023-11-29 | Giuseppe Scalabrino | Epidermal growth factor (egf) and variants thereof for treating or preventing inflammatory demyelinating disorders |
WO2024124507A1 (en) * | 2022-12-15 | 2024-06-20 | Center For Excellence In Brain Science And Intelligence Technology, Chinese Academy Of Sciences | Striatal neural progenitors in treatment of hypoxic-ischemic encephalopathy |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4863899A (en) | 1983-05-09 | 1989-09-05 | Todaro George J | Biologically active polypeptides |
US5240912A (en) | 1983-05-09 | 1993-08-31 | Todaro George J | Transforming growth factor (TGF) peptides |
JPS6034997A (ja) | 1983-05-09 | 1985-02-22 | ジヨージ、ジヨセフ、トダロ | 生物学的活性ポリペプチド類 |
CA1275922C (en) | 1985-11-28 | 1990-11-06 | Harunobu Amagase | Treatment of cancer |
WO1990007007A1 (en) | 1988-12-14 | 1990-06-28 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | Cell culture medium for human liver epithelial cell line |
US5026381A (en) | 1989-04-20 | 1991-06-25 | Colla-Tec, Incorporated | Multi-layered, semi-permeable conduit for nerve regeneration comprised of type 1 collagen, its method of manufacture and a method of nerve regeneration using said conduit |
US5411883A (en) * | 1989-12-26 | 1995-05-02 | Somatix Therapy Corporation | Proliferated neuron progenitor cell product and process |
US5981165A (en) | 1991-07-08 | 1999-11-09 | Neurospheres Holdings Ltd. | In vitro induction of dopaminergic cells |
US6071889A (en) | 1991-07-08 | 2000-06-06 | Neurospheres Holdings Ltd. | In vivo genetic modification of growth factor-responsive neural precursor cells |
US5750376A (en) | 1991-07-08 | 1998-05-12 | Neurospheres Holdings Ltd. | In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny |
WO1993001275A1 (en) | 1991-07-08 | 1993-01-21 | Neurospheres Ltd. | NOVEL GROWTH FACTOR-RESPONSIVE PROGENITOR CELLS WHICH CAN BE PROLIFERATED $i(IN VITRO) |
US5980885A (en) | 1991-07-08 | 1999-11-09 | Neurospheres Holdings Ltd. | Growth factor-induced proliferation of neural precursor cells in vivo |
US5851832A (en) | 1991-07-08 | 1998-12-22 | Neurospheres, Ltd. | In vitro growth and proliferation of multipotent neural stem cells and their progeny |
ATE262912T1 (de) | 1993-01-29 | 2004-04-15 | Neurospheres Holdings Ltd | Genetische modifikation von neuralen stammzellen |
ES2265146T3 (es) * | 1993-08-26 | 2007-02-01 | Genetics Institute, Llc | Proteinas morfogeneticas oseas humanas para uso en regeneracion nerviosa. |
US5800812A (en) * | 1995-09-15 | 1998-09-01 | Yeda Research And Development Co. Ltd. | Methods of use of mononuclear phagocytes to promote axonal regeneration |
CA2266659A1 (en) | 1996-11-15 | 1998-05-28 | Paule Poulin | Pretreatment with growth factors to protect against cns damage |
JPH10158188A (ja) | 1996-11-29 | 1998-06-16 | Senju Pharmaceut Co Ltd | 角膜治療用組成物 |
AU743251B2 (en) * | 1997-08-04 | 2002-01-24 | Regents Of The University Of California, The | Methods for treating neurological deficits |
US7795202B2 (en) * | 1997-08-04 | 2010-09-14 | Neurorepair, Inc. | Methods for treating a neurological disorder by peripheral administration of a transforming growth factor alpha (TGF-a) |
US6093531A (en) | 1997-09-29 | 2000-07-25 | Neurospheres Holdings Ltd. | Generation of hematopoietic cells from multipotent neural stem cells |
JP2002543096A (ja) | 1999-04-26 | 2002-12-17 | ステム セル ファーマシューティカルズ,インコーポレーテッド | TGF−αポリペプチド、機能性断片およびそれらの利用法 |
US20020099008A1 (en) | 1999-04-26 | 2002-07-25 | Daniel R. Twardzik | Method for stimulating hematopoiesis using tgf-alpha |
US20020193301A1 (en) | 1999-08-19 | 2002-12-19 | Stem Cell Pharmaceuticals, Inc. | TGF-alpha polypeptides, functional fragments and methods of use therefor |
US6815418B2 (en) | 1999-08-19 | 2004-11-09 | Kaleidos Pharma, Inc. | TGF-α polypeptides, functional fragments and methods of use therefor |
US6677307B2 (en) | 1999-08-19 | 2004-01-13 | Kaleidos Pharma, Inc. | TGF-α polypeptides, functional fragments and methods of use therefor |
JP2003522131A (ja) | 1999-08-19 | 2003-07-22 | ステム セル ファーマシューティカルズ,インコーポレーテッド | TGF−αポリペプチド、機能性断片およびそれらの利用法 |
-
1998
- 1998-08-04 AU AU86914/98A patent/AU743251B2/en not_active Ceased
- 1998-08-04 KR KR1020007001235A patent/KR20010022641A/ko not_active Application Discontinuation
- 1998-08-04 IL IL13428998A patent/IL134289A0/xx unknown
- 1998-08-04 US US09/129,028 patent/US7790669B1/en not_active Expired - Fee Related
- 1998-08-04 JP JP2000504872A patent/JP2001511456A/ja not_active Withdrawn
- 1998-08-04 CA CA002298506A patent/CA2298506A1/en not_active Abandoned
- 1998-08-04 CN CN98809859A patent/CN1273534A/zh active Pending
- 1998-08-04 WO PCT/US1998/016281 patent/WO1999006060A1/en not_active Application Discontinuation
- 1998-08-04 EP EP98938378A patent/EP0996456A4/en not_active Withdrawn
-
2001
- 2001-07-31 US US09/920,085 patent/US20020004039A1/en not_active Abandoned
-
2010
- 2010-08-26 US US12/869,468 patent/US8158578B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2298506A1 (en) | 1999-02-11 |
US7790669B1 (en) | 2010-09-07 |
WO1999006060A1 (en) | 1999-02-11 |
EP0996456A1 (en) | 2000-05-03 |
EP0996456A4 (en) | 2003-07-09 |
AU743251B2 (en) | 2002-01-24 |
US20110071078A1 (en) | 2011-03-24 |
US20020004039A1 (en) | 2002-01-10 |
JP2001511456A (ja) | 2001-08-14 |
CN1273534A (zh) | 2000-11-15 |
KR20010022641A (ko) | 2001-03-26 |
AU8691498A (en) | 1999-02-22 |
US8158578B2 (en) | 2012-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL134289A0 (en) | Methods for treating neurological deficits | |
HUP0001237A3 (en) | Methods for treating vascular disorders | |
IL126203A0 (en) | Method for treating pain | |
EP0906104A4 (en) | PAIN TREATMENT PROCESS | |
AU9035498A (en) | Method for treating pain | |
HUP0003964A2 (en) | Methods for treating thrombotic disorders | |
HK1010220A1 (en) | Method for surface treatment. | |
IL141263A0 (en) | Methods for treatment of neurological disorders | |
GB9700899D0 (en) | Novel treatment | |
ZA9810405B (en) | Process for treating foods | |
IL126064A0 (en) | Method for treating pain | |
GB9605828D0 (en) | Treatment method | |
EP1009403A4 (en) | METHOD FOR TREATING SCHIZOPHRENIA | |
GB9710990D0 (en) | Modification process | |
GB2329350B (en) | Improved grinding process | |
AU9034798A (en) | Method for treating pain | |
PL340430A1 (en) | Combination for treating aids | |
GB9714841D0 (en) | Treatment method | |
IL131852A0 (en) | Process for stimulating neural regeneration | |
EP1007041A4 (en) | COMPOSITION FOR TREATING PAIN | |
GB9625626D0 (en) | Treatment for copper surfaces | |
ZA981840B (en) | Process for treating wastewater | |
GB2331514B (en) | Effluent treatment | |
EP1094863A4 (en) | METHOD FOR THE TREATMENT OF NEUROLOGICAL INJURIES AND DISEASES | |
GB9714884D0 (en) | Effluent treatment apparatus |